Transplant-associated skin cancer: Role of reducing immunosuppression

11Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

This article explores the role of reducing immunosuppression as a therapeutic strategy for the problem of transplant-associated skin cancer. The specific issue of immunosuppression reduction is based on a brief historic review of the epidemiology of skin cancer in transplant patients, followed by a description of the role of immunosuppression as a cause of skin cancer. Finally, the literature pertaining to the hypothesis that reducing immunosuppression in solid organ transplant recipients favorably impacts both the incidence of cutaneous malignancy and outcomes relating to individual aggressive malignancies is presented. © Journal of the National Comprehensive Cancer Network.

Cite

CITATION STYLE

APA

Neuburg, M. (2007). Transplant-associated skin cancer: Role of reducing immunosuppression. JNCCN Journal of the National Comprehensive Cancer Network. Jones and Bartlett Publishers. https://doi.org/10.6004/jnccn.2007.0047

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free